Paratek Pharmaceuticals, Inc.
PRTK · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $101,705 | $217,386 | $276,534 | $132,151 |
| - Cash | $34,248 | $80,367 | $105,157 | $102,302 |
| + Debt | $258,414 | $255,736 | $252,018 | $262,823 |
| Enterprise Value | $325,871 | $392,755 | $423,395 | $292,672 |
| Revenue | $150,788 | $120,951 | $43,517 | $16,544 |
| % Growth | 24.7% | 177.9% | 163% | – |
| Gross Profit | $127,732 | $99,416 | $34,866 | $13,060 |
| % Margin | 84.7% | 82.2% | 80.1% | 78.9% |
| EBITDA | -$44,900 | -$40,685 | -$73,933 | -$108,543 |
| % Margin | -29.8% | -33.6% | -169.9% | -656.1% |
| Net Income | -$63,566 | -$59,084 | -$116,259 | -$128,790 |
| % Margin | -42.2% | -48.8% | -267.2% | -778.5% |
| EPS Diluted | -1.17 | -1.22 | -2.63 | -3.93 |
| % Growth | 4.1% | 53.6% | 33.1% | – |
| Operating Cash Flow | -$66,141 | -$48,273 | -$103,424 | -$134,045 |
| Capital Expenditures | -$36 | -$373 | -$376 | -$239 |
| Free Cash Flow | -$66,177 | -$48,646 | -$103,800 | -$134,284 |